Macrophage activation syndrome triggered by active systemic lupus erythematosus
Author:
Publisher
Springer Science and Business Media LLC
Subject
Rheumatology
Link
https://link.springer.com/content/pdf/10.1007/s00393-020-00836-w.pdf
Reference10 articles.
1. Castañeda S, Atienza-Mateo B, Martín-Varillas JL, Serra López-Matencio JM, González-Gay MA (2018) Anakinra for the treatment of adult-onset Still’s disease. Expert Rev Clin Immunol 14(12):979–992
2. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124–131
3. Houssiau FA, Vasconcelos C, D’Cruz D, Sebastiani GD et al (2010) The 10-year follow-up data of the Euro-lupus nephritis trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis 69(1):61–64
4. Lyseng-Williamson KA (2018) Anakinra in Still’s disease: a profile of its use. Drugs Ther Perspect 34(12):543–553
5. Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ (2011) Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin‑1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology (Oxford) 50(2):417–419
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Heterogeneity of macrophage activation syndrome and treatment progression;Frontiers in Immunology;2024-04-26
2. Loss of interleukin-1 beta is not protective in the lupus-prone NZM2328 mouse model;Frontiers in Immunology;2023-05-16
3. The role of interleukin 1 in the development of human diseases: focus on Anakinra (IL-1 receptor antagonist);Rheumatology Science and Practice;2022-07-01
4. Macrophage Polarization and Plasticity in Systemic Lupus Erythematosus;Frontiers in Immunology;2021-12-20
5. Crosstalk between Interleukin-1β and Type I Interferons Signaling in Autoinflammatory Diseases;Cells;2021-05-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3